Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 643

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT07526493
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of…
Universal CD19 CAR-γδT Cell Injec… SEP Phase 1 RECRUITING En attente / non publié Tongji Hospital China · Tongji Hospital, Tongji Medical College, Huaz… 2026-04-01 → 2028-12-31 Ouvrir
NCT02040298
ReBUILD — Assessment of Clemastine Fumarate as a Remyelinating Agent in…
Clemastine SEP Phase 2 COMPLETED En attente / non publié University of California, San Fra… United States · UCSF Multiple Sclerosis Center, San F… 2014-01 → 2016-04 Ouvrir
NCT06683612
PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS an…
PIPE-791 SEP Phase 1 COMPLETED En attente / non publié Contineum Therapeutics United Kingdom · Hammersmith Medicines Research, Lond… 2024-12-09 → 2025-06-12 Ouvrir
NCT06711354
B-cell Depletion in Offspring to Women With MS Under Immunomodulatory T…
Anti-CD20 Monoclonal Antibody SEP À vérifier UNKNOWN En attente / non publié Region Stockholm Non communiqué 2025-06 → 2025-12 Ouvrir
NCT04971005
COAST — Ocrelizumab or Alemtuzumab Compared With Autologous Hematopoiet…
Autologous Hematopoietic Stem Cel… SEP Phase 2 TERMINATED En attente / non publié Universitätsklinikum Hamburg-Eppe… Germany · Universitätsklinikum Hamburg-Eppendorf, Ham… 2021-08-27 → 2022-02-04 Ouvrir
NCT02807285
Expanded Access Program for Ocrelizumab in Participants With Primary Pr…
Ocrelizumab SEP À vérifier NO_LONGER_AVAILABLE En attente / non publié Hoffmann-La Roche United States · Abington Neurological Associates, Wil… Non communiqué Ouvrir
NCT05123703
Operetta 2 — A Study to Evaluate Safety and Efficacy of Ocrelizumab in …
Ocrelizumab SEP Phase 3 ACTIVE_NOT_RECRUITING En attente / non publié Hoffmann-La Roche United States, Argentina, Australia, Austria, Belgium… 2022-05-19 → 2029-09-17 Ouvrir
NCT04458688
Investigating the Effect of Ocrelizumab in African Americans and Caucas…
Investigating the Effect of Ocrel… SEP À vérifier RECRUITING En attente / non publié Wayne State University United States · Wayne State University, Detroit, Unit… 2021-11-20 → 2030-12 Ouvrir
NCT06526000
Study to Assess Changes in Immunoglobulins in Patients With Relapsing M…
Study to Assess Changes in Immuno… SEP À vérifier COMPLETED En attente / non publié Novartis United States · Novartis Pharmaceuticals, East Hanove… 2022-10-11 → 2024-02-28 Ouvrir
NCT02708927
EMOSOCIAL-MS — Emotional Processing, Family Life, Friendship and Social…
EMOSOCIAL-MS — Emotional Processi… SEP Non applicable COMPLETED En attente / non publié University Hospital, Bordeaux France · CHU de Bordeaux, Bordeaux, France | CHU de D… 2016-03-03 → 2019-01-28 Ouvrir
NCT05787795
DREAM — Identifying and Characterizing Preclinical MS
DREAM — Identifying and Character… SEP À vérifier RECRUITING En attente / non publié Yale University United States · Yale University, North Haven, United … 2022-06-21 → 2033-06-30 Ouvrir
NCT07789171
Synbiotic-MS — Synbiotic Supplementation as a Part of Dietary Modificat…
Synbiotic-MS — Synbiotic Suppleme… SEP Non applicable COMPLETED En attente / non publié Hacettepe University Turkey (Türkiye) · Hacettepe University, Ankara, Turk… 2020-03-01 → 2023-11-29 Ouvrir
NCT07788859
Reliability and Validity of Three DT-TUG Protocols in MS
Reliability and Validity of Three… SEP À vérifier RECRUITING En attente / non publié Afyonkarahisar Health Sciences Un… Turkey (Türkiye) · SANKO University, Gaziantep, Turke… 2026-03-16 → 2026-09-14 Ouvrir
NCT05999604
WINDOCRE — Impact of Annual Versus Biannual Infusions of Ocrelizumab in…
Ocrelizumab Injection [Ocrevus] SEP Phase 3 ACTIVE_NOT_RECRUITING En attente / non publié Fondation Ophtalmologique Adolphe… France · CH Gonesse, Gonesse, France | CHI Poissy-Sai… 2023-11-09 → 2028-05 Ouvrir
NCT06433752
ENABLE — A Study Evaluating the Real World Experience of Participants T…
ENABLE — A Study Evaluating the R… SEP À vérifier RECRUITING En attente / non publié TG Therapeutics, Inc. United States, Puerto Rico · TG Therapeutics Investig… 2024-07-22 → 2032-04-01 Ouvrir
NCT03553485
Effects of VNS on RT-induced Inflammation and Prognosis of Patients Wit…
transcutaneous vagus nerve stimul… SEP Non applicable UNKNOWN En attente / non publié Kyoungwon Baik Belgium · UZ Brussels, Brussels, Belgium 2018-08-08 → 2019-12 Ouvrir
NCT06554067
Effects of tDCS and VNS on Postoperative Analgesia
Active transcranial direct curren… SEP Non applicable NOT_YET_RECRUITING En attente / non publié Columbia University Non communiqué 2024-08 → 2026-08 Ouvrir
NCT06923007
Advant — Alzheimer's Disease Treated With Vagus Nerve Stimulation
Vagus nerve stimulation SEP Non applicable RECRUITING En attente / non publié Stanford University China · Beijing Tiantan Hospital, Beijing, China 2025-05-07 → 2027-12 Ouvrir
NCT04437498
VNS mTBI — Vagal Nerve Stimulation in mTBI
sham stimulation SEP Non applicable RECRUITING En attente / non publié Medical University of South Carol… United States · Atlanta VA Medical and Rehab Center, … 2021-02-25 → 2026-12-10 Ouvrir
NCT07371676
Effects of Vagus Nerve Stimulation on the Autonomic Nervous System
Stimulation SEP Non applicable COMPLETED En attente / non publié Istanbul Gelisim University Turkey (Türkiye) · Istanbul Gelisim University, Istan… 2024-09-17 → 2025-12-05 Ouvrir
NCT05417711
Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-M…
Transcutaneous Vagus Nerve Stimul… SEP Non applicable NOT_YET_RECRUITING En attente / non publié Sun Yat-Sen Memorial Hospital of … Non communiqué 2023-11-23 → 2026-09-01 Ouvrir
NCT05801809
Understanding the Effects of Transauricular Vagus Nerve Stimulation on …
Transauricular vagus nerve stimul… SEP Non applicable COMPLETED En attente / non publié Spaulding Rehabilitation Hospital United States · Spaulding Hospital Cambridge, Cambrid… 2023-04-26 → 2026-03-01 Ouvrir
NCT06280755
RECLAIM — Clinical Impact Through AI-assisted MS Care - A Retrospective…
RECLAIM — Clinical Impact Through… SEP À vérifier RECRUITING En attente / non publié icometrix Czechia, Germany · ERC Charité - Universitätsmedizin … 2024-03-01 → 2027-04 Ouvrir
NCT00283023
Oligodendrocyte Progenitor Cell Culture From Human Brain
Oligodendrocyte progenitor cell c… SEP Phase 1 COMPLETED En attente / non publié Department of Medical Services Mi… Thailand · Assistant Professor Subsai Kongsaengdao, B… 2007-12 → 2010-12 Ouvrir
NCT07479212
MOGHEAD — Headache Prevalence and Phenotype in Myelin Oligodendrocyte G…
MOGHEAD — Headache Prevalence and… SEP À vérifier NOT_YET_RECRUITING En attente / non publié Fondazione Policlinico Universita… Non communiqué 2026-03-31 → 2026-12 Ouvrir